Physician

Aaron M Amos, MD

According to 2025 Medicare claims, Aaron Amos, MD (NPI: 1881689479) practices urology in the Fort Worth-Arlington-Grapevine, TX market, with the plurality of this provider's patient population coming from Tarrant, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1033386578; TIN: 752131429) and primary practice location at 76017-5871. Amos is affiliated with the WellMed Texas Medicare ACO, LLC (ACO ID: A4889) and UT Southwestern Accountable Care Network (ACO ID: D0211), participating under both the MSSP and REACH models.

Amos' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 618 traditional Medicare patients, billed 2,861 HCPCS/CPT codes, and received $173,249 in Medicare payments. The top billing code was 52000 (Diagnostic exam of bladder and urethra using an endoscope). Part D data shows 4,174 prescription claims across 864 beneficiaries totaling $240,470 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 135 claims. Open Payments data shows 11 records totaling $240. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $242 to $427.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	788	35,893	$215,839
2016	855	40,234	$229,476
2017	848	7,706	$205,294
2018	874	6,524	$207,952
2019	923	8,143	$226,781
2020	772	5,453	$147,711
2021	777	5,337	$200,691
2022	665	4,573	$174,875
2023	661	5,250	$183,829
2024	618	2,861	$173,249

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	615	2,958	$257,962
2016	662	3,281	$280,707
2017	678	3,574	$301,014
2018	831	4,198	$347,599
2019	937	4,705	$385,694
2020	893	4,254	$323,458
2021	851	4,334	$281,165
2022	823	4,244	$294,161
2023	858	4,495	$265,108
2024	864	4,174	$240,470

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	76	$21,179
2016	N/R	90	$18,905
2017	N/R	82	$24,588
2018	N/R	108	$28,897
2019	N/R	148	$51,843
2020	N/R	152	$64,232
2021	N/R	148	$61,305
2022	13	154	$56,593
2023	N/R	164	$75,942
2024	N/R	135	$62,024

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
52000	Diagnostic exam of bladder and urethra using an endoscope	88	98	$184
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	90	124	$139
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	540	1,019	$90
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	251	382	$13
81003	Automated urinalysis test	172	233	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	147	6,971	$109,401
Tamsulosin Hcl	Tamsulosin Hcl	917	72,411	$15,209
Mirabegron Er	Mirabegron	33	1,590	$14,568
Gemtesa	Vibegron	14	790	$12,634
Finasteride	Finasteride	804	64,745	$10,210

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	41	$46,539
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	68	$15,058
A4332	Lubricant, individual sterile packet, each	N	N/R	26	$427

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	11	$240	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aaron M. Amos, MD?

Tedicare shows public-source Medicare data for Aaron M. Amos, MD (NPI 1881689479), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron M. Amos, MD have ACO affiliation data?

Aaron M. Amos, MD is shown with ACO affiliation data for WellMed Texas Medicare ACO, LLC (MSSP, ACO ID A4889) and UT Southwestern Accountable Care Network (REACH, ACO ID D0211).

What billing organization is linked to Aaron M. Amos, MD?

Aaron M. Amos, MD is linked to TEXAS ONCOLOGY PA (billing NPI 1033386578) in the available physician profile data.

Does Aaron M. Amos, MD have Open Payments data?

Aaron M. Amos, MD has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.